Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study

Study:

CRT-D Based Heart Failure Monitoring Study

Rationale:

n/a

Purpose:

The purpose of this study is to collect and analyze electrical measurements, timing, and signals from a CRT-D device in heart failure patients who either already have an implanted left atrial pressure sensor or will undergo a simultaneous implantation of a left atrial pressure sensor and a CRT-D device. These devices may be placed at the same time or separately (staged procedure) at the discretion of the investigator. A comparison will be made between the information gathered from the CRT-D system and the information gathered by the left atrial pressure sensor.

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Heart Failure Device: Cardiac resynchronization therapy and HeartPODĀ® system Phase 2

Verified by St. Jude Medical December, 2012

Sponsored by: St. Jude Medical
Information provided by: St. Jude Medical
ClinicalTrials.gov identifier: NCT00632372

Study Type: Interventional

Study Design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

The Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

Richard Troughton, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site